SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA

NCT07746570 | Completed

• 1 other identifier: 2025-663
• Study Type: interventional
• Target: 26
• Locations: 1 country
• Sites: 1

Brief Summary

Asthma is a long-term lung disease that can make breathing difficult and can also affect sleep. Even with regular medical treatment, many people with asthma continue to experience shortness of breath and insomnia. This study will examine whether Su Jok therapy, a complementary therapy that applies gentle stimulation to specific points on the hands and feet, can help reduce shortness of breath and improve sleep in people with asthma. Adults with asthma who agree to participate will be randomly assigned to one of two groups. One group will receive Su Jok therapy in addition to their usual care, while the other group will receive usual care only. Researchers will compare changes in breathing difficulty and sleep quality between the two groups. The results of this study may help determine whether Su Jok therapy can be used as a safe and supportive treatment alongside standard asthma care.

Conditions

Asthma; Dyspnea; Insomnia

Keywords

Insomnia; INSOMNİA; su jok; asthma

Outcome Measures

Primary Outcomes (1)

• Dyspnea severity

  Dyspnea severity will be assessed using the Visual Analog Scale (VAS). Higher scores indicate greater dyspnea severity.

  Baseline and daily for 5 consecutive days, with post-intervention assessment on Day 5.

Secondary Outcomes (1)

• Insomnia severity

  Baseline and post-intervention (Day 5).

Study Arms (2)

Su Jok Therapy Group

EXPERIMENTAL

Participants in this group will receive routine asthma care plus five consecutive daily sessions of Su Jok therapy. Dyspnea and insomnia symptoms will be assessed daily using the Visual Analog Scale (VAS). Questionnaire data will be collected before the intervention (baseline) and after completion of the intervention (post-test).

Other: su jok therapy

Control Group

NO INTERVENTION

Participants in this group will receive routine asthma care only. Dyspnea and insomnia symptoms will be assessed daily for five consecutive days using the Visual Analog Scale (VAS). Questionnaire data will be collected at baseline and after the study period (post-test).

Interventions

su jok therapy OTHER

Su Jok therapy was administered by the researcher once daily for five consecutive days in addition to routine asthma care. The intervention involved stimulation of predefined Su Jok correspondence points on the hands according to the study protocol. Each session was performed using standardized procedures to ensure consistency throughout the study.

Su Jok Therapy Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 18 years or older.
• Diagnosed with asthma by a physician.
• A baseline Visual Analog Scale (VAS) score of 3 or higher for both dyspnea and insomnia.
• Receiving routine asthma treatment.
• Able to communicate in Turkish.
• Able to understand the study procedures and provide written informed consent.
• Willing to participate in the study.

You may not qualify if:

• Presence of severe cognitive or psychiatric disorders that could interfere with participation.
• Presence of skin lesions, infection, or injury on the hands that would prevent Su Jok therapy.
• Participation in another clinical trial during the study period.
• Withdrawal of consent at any stage of the study.

Sponsors & Collaborators

• Erzincan Binali Yildirim Universitesi: lead

Study Sites (1)

Erzincan Binali Yıldırım University

Erzincan, Merkez, 24100, Turkey (Türkiye)

Location

Related Links

• The Effects of Su Jok Therapy on Pain, Fatigue, Insomnia, Nausea, and Vomiting Experienced by Patients With Gastrointestinal System Cancer: A Randomized Trial

MeSH Terms

Conditions

Asthma; Dyspnea; Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: July 31, 2026
• First Posted: August 5, 2026
• Study Start: January 2, 2026
• Primary Completion: July 31, 2026
• Study Completion: August 1, 2026
• Last Updated: August 6, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)